Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome | Zendy

Harold Bays | Zendy; Christie M. Ballantyne | Zendy; Rene A. Braeckman | Zendy; William G. Stirtan | Zendy; Ralph T. Doyle | Zendy; Sephy Philip | Zendy; Paresh N. Soni | Zendy; Rebecca A. Juliano | Zendy

Open Access

Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome

Author(s) -

Harold Bays,

Christie M. Ballantyne,

Rene A. Braeckman,

William G. Stirtan,

Ralph T. Doyle,

Sephy Philip,

Paresh N. Soni,

Rebecca A. Juliano

Publication year - 2015

Publication title -

metabolic syndrome and related disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.598

H-Index - 45

eISSN - 1557-8518

pISSN - 1540-4196

DOI - 10.1089/met.2014.0137

Subject(s) - medicine , eicosapentaenoic acid , statin , placebo , triglyceride , apolipoprotein b , endocrinology , metabolic syndrome , c reactive protein , lipoprotein , cholesterol , gastroenterology , fatty acid , biochemistry , inflammation , polyunsaturated fatty acid , pathology , chemistry , obesity , alternative medicine

The aim of this analysis was to examine the effects of icosapent ethyl (eicosapentaenoic acid ethyl ester, IPE) on high-sensitivity C-reactive protein (hsCRP) and lipid parameters in patients with metabolic syndrome, with and without stable statin therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research